Non-invasive Prenatal Diagnostics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Non-invasive Prenatal Diagnostics Market to 2027 - Global Analysis and Forecasts by Product (Instruments and Consumables), Application (Microdeletion Syndrome, Trisomy and Others), End User (Hospitals, Diagnostic Laboratories and Other) and Geography

Report Code: TIPRE00003140 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Non-invasive prenatal diagnostic is an emerging genetic test that is used to screen for the birth defects and inherited diseases. The test utilizes small amount of the babies DNA to screen the down syndrome, trisomy 14 and 18, along with the inherited diseases such as cystic fibrosis, hemophilia, and other conditions.

The non-invasive prenatal diagnostics market is expected to grow in the forecast period owing to key factors such as rise in the population, increase in the demand for the non-invasive prenatal diagnostic testing products and others. The market is likely to experience the growth opportunities in the emerging nations and the technological advancements are likely to develop innovative products.

The "Global Non-invasive Prenatal Diagnostics Market Analysis to 2027" is a specialized and in-depth study of the medical devices industry with a focus on the global market trend. The report aims to provide an overview of global non-invasive prenatal diagnostics market with detailed market segmentation by product, application, end user and geography. The global non-invasive prenatal diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Non-invasive prenatal diagnostics market players and offers key trends and opportunities in the market.

The global non-invasive prenatal diagnostics market is segmented on the basis of product, application and end user. Based product, the market is segmented as instruments and consumables. On the basis of the application the market segmentation is classified as microdeletion syndrome, trisomy and others. Based on the end user the market is segmented as hospitals, diagnostics laboratories and others.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global non-invasive prenatal diagnostics market based on product, application and end user. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The non-invasive prenatal diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the non-invasive prenatal diagnostics market in the forecast period. Asia Pacific is anticipated to be the fastest growing region due to the increasing number of pregnancies, increasing risk of premature deliveries due to unhealthy lifestyle and increase in the demand of the NIPT products.

The report analyzes factors affecting non-invasive prenatal diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the non-invasive prenatal diagnostics market in these regions.

The report also includes the profiles of key non-invasive prenatal diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the non-invasive prenatal diagnostics market include, Thermo Fisher Scientific, Inc., Illumina, Inc., Pacific Biosciences of California, Inc., Perkinelmer, Inc., Qiagen, F. Hoffmann-La Roche Ltd, BGI, Agilent Technologies, Inc., Eurofins Scientific and Quest Diagnostics Incorporated.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1. Non-invasive Prenatal Diagnostics Market- By Product
1.3.2. Non-invasive Prenatal Diagnostics Market- By Application
1.3.3. Non-invasive Prenatal Diagnostics Market- By End User
1.3.4. Non-invasive Prenatal Diagnostics Market- By Region
1.3.4.1. By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NONINVASIVE PRENATAL DIAGNOSTICS MARKET LANDSCAPE
4.1. MARKET OVERVIEW
4.2. PEST ANALYSIS
4.2.1. North America - PEST Analysis
4.2.2. Europe - PEST Analysis
4.2.3. Asia Pacific - PEST Analysis
4.2.4. Middle East & Africa - PEST Analysis
4.2.5. South and Central America - PEST Analysis

5. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET- KEY INDUSTRY DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET- GLOBAL ANALYSIS
6.1. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET - GLOBAL MARKET OVERVIEW
6.2. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/ MARKET SHARE OF KEY PLAYERS

7. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. INSTRUMENTS MARKET
7.3.1. Overview
7.3.2. Instruments Market Forecast and Analysis (US$ Mn)
7.3.3. Ultrasound Devices Market
7.3.3.1. Overview
7.3.3.2. Ultrasound Devices Market Forecast and Analysis (US$ Mn)
7.3.4. NGS Systems Market
7.3.4.1. Overview
7.3.4.2. NGS Systems Market Forecast and Analysis (US$ Mn)
7.3.5. PCR Instruments Market
7.3.5.1. Overview
7.3.5.2. PCR Instruments Market Forecast and Analysis (US$ Mn)
7.3.6. Others Market
7.3.6.1. Overview
7.3.6.2. Others Market Forecast and Analysis (US$ Mn)
7.4. CONSUMABLES MARKET
7.4.1. Overview
7.4.2. Consumables Forecast and Analysis (US$ Mn)
8. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. MICRODELETION SYNDROME MARKET
8.3.1. Overview
8.3.2. Microdeletion Syndrome Market Forecast and Analysis (US$ Mn)
8.4. TRISOMY MARKET
8.4.1. Overview
8.4.2. Trisomy Market Forecast and Analysis (US$ Mn)
8.5. OTHERS MARKET
8.5.1. Overview
8.5.2. Others Modelling Market Forecast and Analysis (US$ Mn)

9. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS MARKET
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis (US$ Mn)
9.4. DIAGNOSTIC LABORATORIES MARKET
9.4.1. Overview
9.4.2. Diagnostic Laboratories Market Forecast and Analysis (US$ Mn)
9.5. OTHERS MARKET
9.5.1. Overview
9.5.2. Others Modelling Market Forecast and Analysis (US$ Mn)
?
10. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.1.1. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.1.2. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.3. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.4. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.5. North America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.1.6. US Market Overview
10.1.6.1. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.6.2. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.6.3. US Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.7. Canada Market Overview
10.1.7.1. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.7.2. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.7.3. Canada Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.1.8. Mexico Market Overview
10.1.8.1. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.1.8.2. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.1.8.3. Mexico Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2. EUROPE NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.2.1. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.2.2. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.3. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.4. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.5. Europe Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.2.6. UK Market Overview
10.2.6.1. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.6.2. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.6.3. UK Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.7. Germany Market Overview
10.2.7.1. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.7.2. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.7.3. Germany Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.8. France Market Overview
10.2.8.1. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.8.2. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.8.3. France Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.9. Italy Market Overview
10.2.9.1. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.9.2. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.9.3. Italy Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.2.10. Spain Market Overview
10.2.10.1. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.2.10.2. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.2.10.3. Spain Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3. ASIA PACIFIC NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.3.1. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.3.2. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.3. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.4. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.5. Asia Pacific Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.3.6. Japan Market Overview
10.3.6.1. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.6.2. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.6.3. Japan Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.7. India Market Overview
10.3.7.1. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.7.2. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.7.3. India Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.8. China Market Overview
10.3.8.1. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.8.2. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.8.3. China Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.9. South Korea Market Overview
10.3.9.1. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.9.2. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.9.3. South Korea Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.3.10. Australia Market Overview
10.3.10.1. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.3.10.2. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.3.10.3. Australia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4. MIDDLE EAST & AFRICA (MEA) NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.4.1. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.4.2. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.3. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.4. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.5. Middle East & Africa (MEA) Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.4.6. South Africa Market Overview
10.4.6.1. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.6.2. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.6.3. South Africa Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.7. Saudi Arabia Market Overview
10.4.7.1. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.7.2. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.7.3. Saudi Arabia Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.4.8. UAE Market Overview
10.4.8.1. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.4.8.2. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.4.8.3. UAE Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5. SOUTH AND CENTRAL AMERICA NON-INVASIVE PRENATAL DIAGNOSTICS MARKET
10.5.1. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis (US$ Mn)
10.5.2. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.3. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.4. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.5. South and Central America Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Country
10.5.6. Brazil Market Overview
10.5.6.1. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.6.2. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.6.3. Brazil Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)
10.5.7. Argentina Market Overview
10.5.7.1. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Product (US$ Mn)
10.5.7.2. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By Application (US$ Mn)
10.5.7.3. Argentina Non-invasive Prenatal Diagnostics Market Forecasts and Analysis - By End User (US$ Mn)

11. INDUSTRY LANDSCAPE
11.1. ORGANIC GROWTH STRATEGIES
11.1.1. New Product Launches
11.1.2. Marketing & Promotional Activities
11.2. INORGANIC GROWTH STRATEGIES
11.2.1. Partnerships, Collaborations, and Joint Ventures
11.2.2. Mergers & Acquisitions

12. NON-INVASIVE PRENATAL DIAGNOSTICS MARKET, KEY COMPANY PROFILES
12.1. THERMO FISHER SCIENTIFIC, INC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Financial Overview
12.1.4. Product/Service Portfolio
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ILLUMINA, INC
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Financial Overview
12.2.4. Product/Service Portfolio
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. PACIFIC BIOSCIENCIES OF CALIFORNIA, INC
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Financial Overview
12.3.4. Product/Service Portfolio
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. PERKIN ELMER, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Financial Overview
12.4.4. Product/Service Portfolio
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. QIAGEN
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Financial Overview
12.5.4. Product/Service Portfolio
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. F. HOFFMANN-LA ROCJE LTD
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Financial Overview
12.6.4. Product/Service Portfolio
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BGI
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Financial Overview
12.7.4. Product/Service Portfolio
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. AGILENT TECHNOLOGIES, INC
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Financial Overview
12.8.4. Product/Service Portfolio
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. EUROFINS SCIENTIFIC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Financial Overview
12.9.4. Product/Service Portfolio
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. QUEST DIAGNOSTICS INCORPORATED
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Financial Overview
12.10.4. Product/Service Portfolio
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS

NOTE:
• This ToC is tentative in nature and is subject to further refinement during the course of the research study
• The list of company profiles included in this ToC is tentative. Profiles of specific players, if required, shall be added to the report upon request.
• Financials can be provided to the extent of availability in the public domain.
The List of Companies

1. Thermo Fisher Scientific, Inc.
2. Illumina, Inc.
3. Pacific Biosciences of California, Inc.
4. Perkinelmer, Inc.
5. QIAGEN
6. F. Hoffmann-La Roche Ltd
7. BGI
8. Agilent Technologies, Inc.
9. Eurofins Scientific
10. Quest Diagnostics Incorporated